Practical management of primary biliary cholangitis
- 1 January 2021
- journal article
- review article
- Published by Sociedad Espanola de Patologia Digestiva (SEPD) in Revista Española de Enfermedades Digestivas
- Vol. 114 (7), 410-417
- https://doi.org/10.17235/reed.2021.8219/2021
Abstract
Primary biliary cholangitis (PBC) is a chronic, cholestatic liver disease of autoimmune pathogenesis that mainly affects middle-aged women. Patients show elevated alkaline phosphatase and bilirubin levels as the disease progresses. The main symptoms of the disease are pruritus and fatigue, which interfere with the quality of life of patients. Progressive damage leading to end-stage liver disease may require liver transplantation. Despite the efficacy of ursodeoxycholic acid (UDCA), the current standard of care for PBC, up to 40 % of patients have an inadequate response to treatment, requiring a second-line therapy. Obeticholic acid is the only second-line treatment approved for PBC in combination with UDCA in adults with inadequate response to UDCA, or as monotherapy in patients intolerant to UDCA. Although different clinical guidelines for the diagnosis and management of PBC have been published, PBC remains challenging for many physicians. In this article we briefly review the main characteristics of the disease and include a practical, user-friendly algorithm for the diagnosis and management of PBC that was developed by Spanish PBC experts based on the European Association for the Study of the Liver recommendations.Keywords
This publication has 66 references indexed in Scilit:
- Sex and Age Are Determinants of the Clinical Phenotype of Primary Biliary Cirrhosis and Response to Ursodeoxycholic AcidGastroenterology, 2013
- Optimizing biochemical markers as endpoints for clinical trials in primary biliary cirrhosisLiver International, 2011
- Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreementPathology International, 2010
- Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assayJournal of Hepatology, 2008
- Rifampin is safe for treatment of pruritus due to chronic cholestasis: a meta‐analysis of prospective randomized‐controlled trialsLiver International, 2006
- Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis GroupJournal of Hepatology, 2004
- Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: What is the risk?Journal of Hepatology, 1992
- Primary Biliary Cirrhosis: Clinical Features and Outcome, with Special Reference to Asymptomatic DiseaseScandinavian Journal of Gastroenterology, 1989
- Positive antimitochondrial antibody but normal alkaline phosphatase: Is this primary biliary cirrhosis?Journal of Hepatology, 1986
- The Prognostic Importance of Clinical and Histologic Features in Asymptomatic and Symptomatic Primary Biliary CirrhosisThe New England Journal of Medicine, 1983